Local Institution

Southampton, Hampshire SO9 4XY

0 studies enrolling now · 8 studies all time

What they study most

High Risk Stage III Melanoma, Leukemia, Pediatric, Lung Cancer - Non Small Cell Squamous, Lymphoma, Lymphoma. Non-Hodgkin, Rheumatoid Arthritis (RA), Squamous Cell Carcinoma of the Head and Neck, Unresectable or Metastatic Melanoma

Studies at this site

• Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) — Completed
• A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) — Completed
• Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) — Completed
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) — Completed
• Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed
• Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma — Completed
• Methotrexate-Inadequate Response Study — Completed